Influenza B, often called “B flu,” is one of two main types of flu virus that cause seasonal illness in humans. Unlike influenza A, which circulates in birds, pigs, and other animals, influenza B is found almost exclusively in people. It causes the same core illness as influenza A (fever, body aches, cough, fatigue) but has some distinct characteristics worth understanding, especially for parents of young children.
How Influenza B Differs From Influenza A
The biggest biological difference is host range. Influenza A viruses jump between species: birds, pigs, horses, and humans all serve as hosts, and these cross-species leaps are what create pandemic strains. Influenza B is endemic in humans and is not widely found in other species. That means it doesn’t produce pandemics, but it reliably shows up every flu season and can still cause severe illness.
Influenza B also mutates differently. It evolves more slowly than influenza A, which is one reason it doesn’t generate the dramatic new strains that spark global outbreaks. However, it still changes enough from year to year that your immune system may not fully recognize it from one season to the next. The virus has historically split into two distinct lineages, called B/Victoria and B/Yamagata, which are different enough that immunity against one does not protect well against the other.
A notable recent shift: the Yamagata lineage has not been detected anywhere in the world since March 2020. The FDA now considers it no longer a public health threat. That leaves B/Victoria as the only influenza B lineage currently circulating, which is why seasonal flu vaccines switched from a four-strain formula to three strains starting with the 2024-2025 season.
Symptoms of Influenza B
Influenza B produces the same general symptoms as influenza A. Most people experience a sudden onset of fever, chills, muscle aches, headache, sore throat, dry cough, and fatigue. Some people, particularly children, also develop nausea, vomiting, or diarrhea. The illness typically hits harder and faster than a common cold, with fever and body aches dominating the first few days.
There’s a common perception that B flu is “milder” than A flu. In population-level data, influenza A causes more total hospitalizations and deaths simply because it’s more common. During the 2024-2025 season, for example, influenza A accounted for 86% of pediatric flu deaths while influenza B accounted for 14%. But that gap largely reflects how many more people catch influenza A in a given year, not that an individual case of B flu is necessarily less dangerous. For the person who has it, influenza B can be just as severe.
Who Is Most at Risk
Influenza B tends to hit children and young adults particularly hard. In some seasons, influenza B accounts for a disproportionate share of pediatric hospitalizations relative to its overall prevalence. Young children are especially vulnerable because they’ve had fewer prior exposures and less accumulated immunity.
The complications that can develop from any flu infection, including B flu, are serious. Among children who died from influenza during the 2024-2025 season, the most common complications before death were sepsis or shock (50%), pneumonia (38%), acute respiratory distress (28%), seizures (24%), and brain inflammation (18%). Adults over 65, pregnant women, and people with chronic conditions like asthma, diabetes, or heart disease also face elevated risk from any flu type.
How It Spreads
Influenza B spreads the same way as influenza A: through respiratory droplets produced when an infected person coughs, sneezes, or talks, and occasionally through touching contaminated surfaces and then touching your face. The incubation period is typically one to four days after exposure.
You become contagious about one day before your symptoms start, which is part of what makes flu so difficult to contain. Most adults continue shedding the virus for roughly five to seven days after symptoms begin. Children and people with weakened immune systems may be contagious for longer.
Testing and Diagnosis
Rapid flu tests available at most clinics and pharmacies can detect influenza, but not all of them distinguish between type A and type B. More advanced molecular tests (PCR-based) can identify the specific type. In practice, the distinction rarely changes how your illness is treated, but it does help public health officials track which strains are circulating and whether vaccines are well matched to the season.
Treatment Options
Four antiviral medications are currently approved for treating influenza B. Three of them work by blocking an enzyme the virus needs to spread between cells: oseltamivir (Tamiflu), zanamivir (Relenza), and peramivir (Rapivab). The fourth, baloxavir (Xofluza), uses a different mechanism but is also effective against both influenza A and B.
The key factor with all of these medications is timing. They work best when started within 48 hours of symptom onset. After that window, the benefit drops significantly. Antivirals don’t cure the flu instantly, but they can shorten the illness by about a day and reduce the risk of serious complications, which matters most for high-risk groups. Baloxavir has the advantage of being a single-dose treatment rather than a multi-day course.
For most otherwise healthy adults, B flu resolves on its own within a week or so with rest, fluids, and over-the-counter medications to manage fever and pain. Antiviral treatment is most important for young children, older adults, pregnant women, and anyone with underlying health conditions.
Vaccination and Prevention
The seasonal flu vaccine is reformulated every year based on which strains are expected to circulate. For the 2024-2025 season, vaccines contain a B/Victoria lineage component alongside two influenza A strains. Because the Yamagata lineage has disappeared from circulation, it was dropped from the vaccine, simplifying the formula from four components to three.
Flu vaccines don’t always perfectly match the circulating strains, and their effectiveness varies from year to year. Even when the match isn’t ideal, vaccination reduces the severity of illness and the likelihood of hospitalization. This is especially meaningful for influenza B, where children bear a disproportionate burden. Standard prevention measures also help: frequent handwashing, avoiding close contact with sick individuals, and staying home when you’re symptomatic, remembering that you’re contagious starting about a day before you feel sick.